Comparing genomic and histologic correlations to radiographic changes in tumors: a murine SCC VII model study.

[1]  M. Dewhirst,et al.  Magnetic resonance imaging applications in the evaluation of tumor angiogenesis. , 2001, Seminars in radiation oncology.

[2]  C. Dinarello.  The role of the interleukin-1-receptor antagonist in blocking inflammation mediated by interleukin-1. , 2000, The New England journal of medicine.

[3]  J. Westermarck,et al.  Regulation of matrix metalloproteinase expression in tumor invasion , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[4]  N. Sampas,et al.  Molecular classification of cutaneous malignant melanoma by gene expression profiling , 2000, Nature.

[5]  J. Homer,et al.  Angiogenesis in head and neck squamous cell carcinoma. , 2000, Clinical otolaryngology and allied sciences.

[6]  M. Koutsilieris,et al.  Mast cell-tumor cell interactions: for or against tumour growth and metastasis? , 1997, Anticancer research.

[7]  P. Glazer,et al.  Genomic instability in cancer. , 2001, Novartis Foundation symposium.

[8]  S. Nicosia,et al.  Vascular endothelial growth factor, platelet-derived growth factor, and insulin-like growth factor-1 promote rat aortic angiogenesis in vitro. , 1994, The American journal of pathology.

[9]  P. Cohen,et al.  Role of insulin‐like growth factors and their binding proteins in growth control and carcinogenesis , 2000, Journal of cellular physiology.

[10]  W. Hong,et al.  Expression of vascular endothelial growth factor and microvessel density in head and neck tumorigenesis. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[11]  M. Miettinen.  Immunohistochemistry of Soft Tissue Tumors: A Review , 1999 .

[12]  Thomas D. Wu,et al.  Analysing gene expression data from DNA microarrays to identify candidate genes , 2001, The Journal of pathology.

[13]  G. Yancopoulos,et al.  Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. , 1999, Genes & development.

[14]  F. Denizot,et al.  Novel structures CTLA‐2α and CTLA‐2β expressed in mouse activated T cells and mast cells and homologous to cysteine proteinase proregions , 1989 .

[15]  P. Bork.  The modular architecture of a new family of growth regulators related to connective tissue growth factor , 1993, FEBS letters.

[16]  M. Mizumoto,et al.  Implications of human macrophage metalloelastase and vascular endothelial growth factor gene expression in angiogenesis of hepatocellular carcinoma. , 2000, Annals of surgery.

[17]  In‐San Kim,et al.  A TGF‐β‐inducible cell adhesion molecule, βig‐h3, is downregulated in melorheostosis and involved in osteogenesis , 2000 .

[18]  J. Mesirov,et al.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.

[19]  D. M. Brown,et al.  Radiosensitization by intratumoral administration of cisplatin in a sustained-release drug delivery system. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[20]  R. Margolskee,et al.  Extracellular Matrix-Associated Protein Sc1 Is Not Essential for Mouse Development , 2000, Molecular and Cellular Biology.

[21]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[22]  Eric S. Lander,et al.  Genomic analysis of metastasis reveals an essential role for RhoC , 2000, Nature.

[23]  N. van Bruggen,et al.  Assessing tumor angiogenesis using macromolecular MR imaging contrast media , 1997, Journal of magnetic resonance imaging : JMRI.

[24]  N. van Bruggen,et al.  Magnetic resonance imaging detects suppression of tumor vascular permeability after administration of antibody to vascular endothelial growth factor. , 1998, Cancer investigation.

[25]  E. Sage,et al.  PDGF-BB modulates endothelial proliferation and angiogenesis in vitro via PDGF beta-receptors , 1994, The Journal of cell biology.

[26]  A. Maity,et al.  Hypoxia and VEGF mRNA expression in human tumors. , 2001, Neoplasia.

[27]  D. Higgs,et al.  The mouse alpha-globin locus regulatory element. , 1995, Blood.

[28]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[29]  G. Shi,et al.  Functional genomics guided with MR imaging: mouse tumor model study. , 2003, Radiology.

[30]  A. Cochran.  The pathologist's role in sentinel lymph node evaluation. , 2000, Seminars in nuclear medicine.

[31]  B. Berk,et al.  Retinoids: versatile biological response modifiers of vascular smooth muscle phenotype. , 2000, Circulation research.

[32]  R. Gillies,et al.  Applications of magnetic resonance in model systems: tumor biology and physiology. , 2000, Neoplasia.

[33]  Christian A. Rees,et al.  Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Napoleone Ferrara,et al.  Clinical applications of angiogenic growth factors and their inhibitors , 1999, Nature Medicine.

[35]  E. Ruoslahti,et al.  Fibronectin and its integrin receptors in cancer. , 1999, Advances in cancer research.

[36]  M. Mizumoto,et al.  Mouse macrophage metalloelastase gene transfer into a murine melanoma suppresses primary tumor growth by halting angiogenesis. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[37]  R. Dunham,et al.  The skeletal muscle alpha-actin gene of channel catfish (Ictalurus punctatus) and its association with piscine specific SINE elements. , 2000, Gene.

[38]  Stefania Forti,et al.  New insights into the role of extracellular matrix during tumor onset and progression , 2002, Journal of cellular physiology.

[39]  C. Heldin,et al.  Mechanism of action and in vivo role of platelet-derived growth factor. , 1999, Physiological reviews.

[40]  M. E. van der Rest,et al.  Collagen family of proteins , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[41]  H. Kuwano,et al.  Significant correlation between expression of heat shock proteins 27, 70 and lymphocyte infiltration in esophageal squamous cell carcinoma. , 2002, Cancer letters.

[42]  P. Boström,et al.  Expression of collagenase‐3 (matrix metalloproteinase‐13) in transitional‐cell carcinoma of the urinary bladder , 2000, International journal of cancer.

[43]  T. Tsuruo,et al.  Involvement of transcriptional repressor ATF3 in acceleration of caspase protease activation during DNA damaging agent‐induced apoptosis , 2001, Journal of cellular physiology.

[44]  C M Kao,et al.  Functional Genomic Technologies: Creating New Paradigms for Fundamental and Applied Biology , 1999, Biotechnology progress.

[45]  V. Kähäri,et al.  Matrix metalloproteinases in tumor invasion , 2000, Cellular and Molecular Life Sciences CMLS.

[46]  L. Suva,et al.  Identification of a novel parathyroid hormone-responsive gene in human osteoblastic cells. , 1999, Bone.

[47]  F. Grosveld,et al.  Mechanisms of developmental control of transcription in the murine alpha- and beta-globin loci. , 1999, Genes & development.

[48]  C. Dinarello,et al.  Biologic basis for interleukin-1 in disease. , 1996, Blood.

[49]  D. Botstein,et al.  A gene expression database for the molecular pharmacology of cancer , 2000, Nature Genetics.